Quality of Life in IIHTT Subjects 6 Months After Diagnosis and Treatment (Video)
Kathleen B. Digre, MD, Professor of Neurology and Ophthalmology, Director of Neuro-Ophthalmology, John A. Moran Eye Center, University of Utah School of Medicine; Beau Bruce, MD, PhD, Emory University
Idiopathic Intracranial Hypertension; Quality of Life (QOL); Headache; NEI VFQ 25; 10 Item supplement; SF36
Quality of Life (QOL) in idiopathic intracranial hypertension (IIH) has been shown to be reduced at diagnosis (baseline visit of the IIHTT). Factors that most affected QOL at baseline were visual symptoms and signs (reduced perimetric mean deviation [PMD], reduced visual acuity, transient visual obscurations, diplopia) and pain symptoms (headache, neck pain). Other influential factors included: dizziness, a positive sleep apnea screening (Berlin Questionnaire) and self-reported cognitive dysfunction. BMI was not associated with the reduced QOL. The baseline IIHTT study showed QOL is reduced in patients with IIH at the time of diagnosis and at a level worse than even that reported by patients with optic neuritis and/or multiple sclerosis.
Relation is Part of
NANOS Annual Meeting 2015 Sizzling Hot Topic: The IIHTT: What Have We Learned?
Spencer S. Eccles Health Sciences Library, University of Utah
2015 North American Neuro-Ophthalmology Society Annual Meeting